Patents
Patents for C07D 231 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings (25,550)
04/2003
04/03/2003WO2003026648A1 4,5-dihydro-1h-pyrazole derivatives having potent cb1-antagonistic activity
04/03/2003WO2003026647A1 Novel 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity
04/03/2003WO2003026415A2 Insecticidal diamides
04/03/2003US20030065187 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
04/03/2003US20030065013 Central nervous system analgesic; hypotensive agents; antiarrhythmia agents; antidiabetic agents
04/03/2003US20030064977 Viricides
04/03/2003US20030064098 Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect
04/03/2003CA2461603A1 Substituted amines for the treatment of neurological disorders
04/03/2003CA2461128A1 Pyrazole derivatives useful in the treatment of hyper-proliferative disorders
04/02/2003EP1296971A2 2-fluorobenzenesulfonyl compounds for the treatment of inflammation
04/02/2003EP1296679A1 Dermal therapeutic system containing non-steroidal antiphlogistics with selective cox-2 inhibition
04/02/2003EP0882029B1 Heterocyclic derivatives as antidiabetic and antiobesity agents
04/02/2003CN1104432C Pyrrole triazines and pyrimidine compound
04/02/2003CN1104429C 4-(3-heterocycly-1-benzoyl) pyrazoles and their use as herbicides
04/02/2003CN1104422C Guanidinyl heterocycle compounds useful as alpha-2 adrenoceptor agonists
04/02/2003CN1104410C Phenyl acetic acid derivatives, process and intermediate products for their production and agents containing them
04/01/2003US6541500 Fungicide mixture
04/01/2003US6541474 Administering a pharmaceutically effective dose of the heterocycle-containing carboxylic acid derivative or salt to a patient suffering form acute promyelocytic leukemia
04/01/2003US6541473 Resorcinol derivatives
04/01/2003US6541209 Bioassay; identification of compounds as agonists; use in treatment of diseases and disorders that are related to 5-HT2A and or 5-HT2C serotonin receptors
04/01/2003CA2273951C Parasiticidal pyrazoles
03/2003
03/27/2003WO2003024958A2 Processes for the preparation of 1,5-diaryl-3-substituted-pyrazoles
03/27/2003WO2003024936A1 Substituted pyrazolo compounds for the treatment of inflammation
03/27/2003WO2003024935A2 Substituted pyrazolyl compounds for the treatment of inflammation
03/27/2003WO2003024448A2 Inhibitors of histone deacetylase
03/27/2003WO2003024446A1 Oxidation stress inhibitor and method of measuring oxidation stress
03/27/2003WO2003024445A1 Drugs comprising combination of antithrombotic agent with pyrazolone derivative
03/27/2003WO2003024400A2 Process for the preparation of 1,5-diarylpyrazoles
03/27/2003WO2001092218A3 Polyamine analogues as therapeutic and diagnostic agents
03/27/2003US20030060453 Such as 4-((4-fluorophenyl)hydrazono)-4H-pyrazole- 3,5-diamine for antiproliferative activity, and promoting apoptosis in cells lacking normal regulation of cell cycle and death
03/27/2003CA2465978A1 Inhibitors of histone deacetylase
03/27/2003CA2460942A1 Substituted pyrazolyl compounds for the treatment of inflammation
03/26/2003EP1294378A2 Thrombopoietin mimetics
03/26/2003CN1406222A Chlorination of an aniline in ortho in a hydrofluoric medium
03/26/2003CN1406128A Use of central cannabinoid receptor antagonist for preparing medicines designed to facilitate smoking cessation
03/26/2003CN1103771C Method for preparing 1-(2-pyridyl) Pyrazole compound
03/26/2003CN1103759C Processes for preparing pesticidal intermediates
03/25/2003US6538116 For therapy of inflammatory or painful disorder
03/25/2003US6538015 Anti-HIV pyrazole derivatives
03/25/2003US6538014 Process for the aggrochemical treatment of rangelands
03/20/2003WO2003022821A1 Heterocycle derivative having 20-hete-producing enzyme inhibitory activity
03/20/2003WO2003022055A1 Pesticidal compositions
03/20/2003WO2002100845A8 Hv protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
03/20/2003WO2002067865A3 N-(aryl)-2-arylethenesulfonamides and therapeutic uses thereof
03/20/2003WO2002048100A3 Thiosulphonic s-esters as material protective agent
03/20/2003US20030055286 Il-8 receptor antagonists
03/20/2003US20030055246 Serine protease inhibitors
03/20/2003US20030055093 For therapy of cardiovascular diseases, stable or unstable angina pectoris, coronary heart disease, stable or unstable angina pectoris, coronary heart disease, Prinzmetal angina, acute coronary syndrome, heart failure, myocardial infarction
03/20/2003US20030055038 For therapy of central nervous system and other disorders
03/20/2003US20030055012 Prodrugs of COX-2 inhibitors
03/20/2003US20030052310 Perfluorinated amide salts and their uses as ionic conducting materials
03/19/2003EP1293997A2 Electrolytic composition, and photoelectrochemical cell
03/19/2003EP1293501A1 Substituted 1-aryl-pyrazoles and their use as pesticides
03/19/2003EP1292577A2 Aryl substituted pyrazoles, triazoles and tetrazoles as sodium channel blocker
03/19/2003EP1292573A2 Substituted thioacetamides
03/19/2003EP0955293B1 Urea derivatives
03/19/2003EP0945439B1 Aminopyrazole derivatives
03/19/2003CN1402979A Substituted phenyl five-membered aza ring herbicide
03/18/2003US6534655 Indeno[1,2-C]pyrazole derivatives for inhibiting tyrosine kinase activity
03/18/2003US6534535 Inhibitors of factor Xa
03/18/2003US6534534 Administering indazole-3-methyleneoxyalkanoic acid derivative to treat atherosclerosis
03/18/2003US6534532 Carbanilides as pesticides
03/18/2003US6534504 Increasing the quantity of meat or improving the quality of meat obtained from a livestock animal, comprising administering to the animal an effective amount of a compound represented by the following structural formula:
03/18/2003US6534492 Uracil substituted phenyl sulfamoyl carboxamides
03/14/2003WO2002022586A1 Indazoles having an action similar to that of a thyroid hormone, method for the production thereof, and their use in medicaments
03/14/2003CA2422353A1 Indazoles having an action similar to that of a thyroid hormone, method for the production thereof, and their use in medicaments
03/13/2003WO2003020217A2 Novel pyrazole analogs acting on cannabinoid receptors
03/13/2003WO2003020029A1 Arylamines as inhibitors of chemokine binding to us28
03/13/2003WO2002078625A3 Therapeutic combinations for cardiovascular and inflammatory indications
03/13/2003US20030050477 Reacting a 2-halo-3-(pyrazol-3-yl)anilide derivative in presence of a transition metal compound of sub gruop VIIa and VIIIa or Ib of periodic table and a base to form the 7-(pyrazol-3-yl)benzoxazole derivative
03/13/2003US20030050254 Derivatives of erythromycin, their preparation process and their use as medicaments
03/13/2003CA2457922A1 Novel pyrazole analogs acting on cannabinoid receptors
03/12/2003EP1289983A2 Heteroarylalkanoic acids as integrin receptor antagonists
03/12/2003EP1289972A1 Serine protease inhibitors
03/12/2003EP1289971A1 Benzamide derivatives and their use as apob-100 and mtp inhibitors
03/12/2003EP1289960A2 Cycloalkyl alkanoic acids as integrin receptor antagonists
03/12/2003EP1289525A2 Tricyclic pyrazole derivatives as protein kinase inhibitors
03/12/2003EP1036058B1 Adamantane derivatives
03/12/2003EP1012144B1 Method for producing (hetero)aromatic hydroxylamines
03/12/2003CN1402713A Control of arthropods in animals
03/12/2003CN1401638A Pyrazoles derivs., Pharmaceutical salt thereof and composition contg. same
03/11/2003US6531501 Veterinary parasiticide
03/11/2003US6531478 For therapy of eating disorder, obesity, bulimia nervosa, diabetes, binge eating, anorexia nervosa, dyslipidimia, hypertension, memory loss, epileptic seizures, migraine, sleep disturbances, pain, sexual/reproductive disorders
03/11/2003US6531449 Hexahydropyrazolo[4,3,-c]pyridine metabolites
03/11/2003US6531269 Color photographic silver halide material
03/11/2003US6531241 Anions of equal number to cations to maintain charge neutrality, are disclosed. These spacer groups may be organic or inorganic in origin and may vary in length. The spacer groups may be saturated, containing single bonds, or may have
03/06/2003WO2003018549A2 Bicyclic compounds as inhibitors of chemokine binding to us28
03/06/2003WO2003018008A1 Apo ai expression accelerating agent
03/06/2003WO2002100844A3 Hiv protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
03/06/2003US20030045581 4-substituted-1- (arylmethylidene) thiosemicarbazide, 4-substituted-1- (arylcarbonyl) thiosemicarbazide and analogs as activators of caspases and inducers of apoptosis and the use thereof
03/06/2003US20030045560 6-(Aryl-amido or aryl-amidomethyl)-naphthalen-2-yloxy-acidic derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1)
03/05/2003EP1288206A1 Substituted benzenesulfonamide derivatives as prodrugs of COX-2 inhibitors
03/05/2003EP1286970A1 Processes for the preparation of pesticidal compounds and novel intermediates thereof
03/05/2003EP1286969A2 Process for the preparation of pesticidal compounds
03/05/2003EP1286953A1 (p-amino-hydroxyphenyl)-acrylamide derivatives and dyes containing said compounds
03/05/2003EP1286670A2 Use of therapeutic benzamide derivatives
03/05/2003EP0946515B1 Parasiticidal pyrazoles
03/05/2003EP0945438B1 Pyrazole derivatives
03/05/2003EP0892791B1 N-[[4-(5-METHYL-3-PHENYLISOXAZOL-4-YL]PHENYL]SULFONYLPROPYLAMIDE and its SODIUMSALT AS PRODRUGS OF COX-2 INHIBITORS
03/05/2003CN1400898A 回旋酶抑制剂及其用途 Gyrase inhibitors and their use